Literature DB >> 24067736

Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma.

Eun Hee Lee1, Kyu Hong Kim2, Jae Hyun Kwon3, Hyung Dong Kim3, Young Zoon Kim4.   

Abstract

OBJECTIVE: This study was undertaken primarily to investigate the possible prognostic values of several cell-cycle regulators for the prediction of functioning pituitary adenoma (FPA) recurrence after surgical resection by immunohistochemically analyzing tumor samples obtained by surgical resection.
METHODS: The medical records of the patients with FPA diagnosed from January 2000 to December 2009 at the Department of Neurosurgery at Samsung Changwon Hospital and Dong-A University Medical Center were selected. Immunohistochemical staining was performed on archived paraffin-embedded tissues obtained by surgical resection for adenohypophysial cells, cell-cycle regulatory proteins (p16, p15, p21, cyclin-dependent kinase [CDK] 4 and 6, phosphorylated retinoblastoma [pRB] protein, and cyclin D1), MIB-1 antigen, and p53.
RESULTS: Of the 174 FPAs, 62 (35.6%) recurred during follow-up period (mean duration 62.4 months, range 24.2-118.9 months). Immunohistochemically, overstaining for p16 in 89 samples (51.1%), p15 in 27 samples (15.5%), p21 in 20 samples (11.5%), CDK4 in 54 samples (31.0%), CDK6 in 18 samples (10.3%), pRB protein in 69 samples (39.7%), and cyclin D1 in 87 samples (50.0%). Multivariate analysis using the Cox proportional hazard regression model showed that invasion into cavernous sinus (hazard ratio [HR] of 4.02; P < 0.001), immunohistochemical normostaining for p16 (HR of 3.16; P < 0.001), immunohistochemical overstaining for pRB protein (HR of 2.45; P = 0.008), cyclin D1 (HR of 2.13; P = 0.029), MIB-1 antigen (HR of 2.74; P = 0.002), and p53 (HR of 2.21; P = 0.002), predicted the recurrence of FPA after surgical resection.
CONCLUSIONS: Our findings indicate that p16, pRB protein, and cyclin D1 are associated with recurrence FPA after surgical resection.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell cycle; Cyclin D1; Pituitary adenoma; RB protein; Recurrence; p16

Mesh:

Substances:

Year:  2013        PMID: 24067736     DOI: 10.1016/j.wneu.2013.09.035

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  9 in total

1.  [The 2017 WHO classification of pituitary tumors].

Authors:  Wolfgang Saeger
Journal:  Pathologe       Date:  2021-04-20       Impact factor: 1.011

Review 2.  Clinical Impact of the Current WHO Classification of Pituitary Adenomas.

Authors:  W Saeger; J Honegger; M Theodoropoulou; U J Knappe; C Schöfl; S Petersenn; R Buslei
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

3.  Immunohistochemical Expression of p16 and p21 in Pituitary Tissue Adjacent to Pituitary Adenoma versus Pituitary Tissue Obtained at Autopsy: Is There a Difference?

Authors:  Emilija Manojlovic Gacic; Milica Skender-Gazibara; Ivan Soldatovic; Dusko Dundjerovic; Novica Boricic; Savo Raicevic; Vera Popovic
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

4.  A Novel Expression Profile of Cell Cycle and DNA Repair Proteins in Nonfunctioning Pituitary Adenomas.

Authors:  Derya Metin-Armagan; Nil Comunoglu; Gulay Bulut; Pinar Kadioglu; Hiraku Kameda; Nurperi Gazioglu; Necmettin Tanriover; Melek Ozturk
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

Review 5.  Genetic aspects of pituitary carcinoma: A systematic review.

Authors:  Zijiang Yang; Ting Zhang; Heng Gao
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  Transcriptome Analysis Showed a Differential Signature between Invasive and Non-invasive Corticotrophinomas.

Authors:  Leonardo Jose Tadeu de Araújo; Antonio Marcondes Lerario; Margaret de Castro; Clarissa Silva Martins; Marcello Delano Bronstein; Marcio Carlos Machado; Ericka Barbosa Trarbach; Maria Candida Barisson Villares Fragoso
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-22       Impact factor: 5.555

7.  Factors That Predict the Growth of Residual Nonfunctional Pituitary Adenomas: Correlations between Relapse and Cell Cycle Markers.

Authors:  Petr Matoušek; Petr Buzrla; Štefan Reguli; Jan Krajča; Jana Dvořáčková; Radim Lipina
Journal:  Biomed Res Int       Date:  2018-07-10       Impact factor: 3.411

8.  Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway.

Authors:  Fangfang Jian; Yufan Chen; Guang Ning; Wei Fu; Hao Tang; Xiao Chen; Yao Zhao; Lili Zheng; Sijian Pan; Weiqing Wang; Liuguan Bian; Qingfang Sun
Journal:  Oncotarget       Date:  2016-02-23

9.  The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence.

Authors:  Jee Soon Kim; Youn Soo Lee; Min Jung Jung; Yong Kil Hong
Journal:  J Pathol Transl Med       Date:  2016-10-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.